0
0
Ness Ziona, Israel – Novel Concepts Medical, a pioneer in plant-based medical treatments, has announced breakthrough results demonstrating a significant reduction in cancer cell viability using its proprietary plant-based formula. In a series of rigorous tests conducted in one of Israel’s premier labs located in Ness Ziona’s science park, the formula achieved a reduction of over 99% in the viability of both breast and lung cancer cells.
The detailed lab results revealed remarkable outcomes:
- MCF-7 breast cancer cells showed a 99.68% decrease in viability after 48 hours of incubation.
- A549 lung cancer cells exhibited a 99.65% decrease in viability after 48 hours of incubation.
Each test was meticulously performed three times to ensure the reliability and accuracy of the findings. These results mark a significant advancement in cancer treatment, providing hope for more effective and less invasive therapeutic options.
Dr. Rachel Alkalay, the founder of Novel Concepts Medical, expressed optimism about the global impact of their discovery. “Our goal is to make this treatment accessible to people worldwide. We are open to collaborations that will help us achieve this mission,” she stated.
Earlier this year, Novel Concepts Medical published a successful case study involving a colon cancer patient. The patient demonstrated notable improvement, with metastases in the liver reducing and the primary tumor shrinking in size after undergoing the plant-based treatment. Importantly, no side effects were reported, underscoring the potential of this treatment to offer a safer alternative to traditional cancer therapies.
The company’s innovative approach and groundbreaking work have not gone unnoticed. In 2023, Novel Concepts Medical was awarded “Most Pioneering Life Savings Treatments R&D Company – Middle East” by Global Health & Pharma Magazine. Additionally, Dr. Alkalay was honored as one of the top three innovative and creative women inventors for 2023 by the FICPI’s World IP Day competition.
As Novel Concepts Medical continues to lead the way in plant-based cancer treatments, the medical community and patients alike eagerly await further developments and potential collaborations that could revolutionize cancer care globally.
